The effect of &#x03B4;-opioid agonists on intracellular calcium level in MOLT-4 T-cell line.
&#x03B4;-opioid agonists were reported to affect T cell functions: proliferation, cytotoxicity, cytokine production. Changes in intracellular calcium level are important in T-cell activation. In this study the effect of the synthetic &#x03B4;-opioid agonist DADLE and an endogenous &#x03B4;-opioid pentapeptide Met-enkephalin on the intracellular calcium level in human T-lymphoblastic leukemia MOLT-4 cells is reported. Intracellular calcium level was monitored using QUIN 2-AM as a fluorescent dye in MOLT-4 cells after short treatment (2 and 15 min) with DADLE and Met-enkephalin. DADLE (10<sup>-8</sup>M) mildly (average 28&#x0025;) decreased the intracellular calcium level after 1 min treatment. The suppressive effect of DADLE (10<sup>-8</sup>M) on the intracellular calcium level was enhanced by longer (15 min) treatment of MOLT-4 cells (average 40&#x0025;). Met-enkephalin (10<sup>-9</sup>M - 10<sup>-7</sup>M) decreased (average 33 &#x0025;) the intracellular calcium level after 2 min treatment (average 33&#x0025; - 37&#x0025;). However, Met-enkephalin (10<sup>-7</sup>M) increased (average 31&#x0025;) the intracellular calcium level after longer (15 min) treatment. Ionophore A23187 (10<sup>-7</sup>M, 10<sup>-6</sup>M) was used as a positive control to enhance intracellular calcium level. Thus, &#x03B4;-opioid agonist DADLE decreased basal intracellular calcium level in MOLT-4 cells after short treatment, while endogenous Met-enkephalin altered intracellular calcium level in a bidirectional way by decreasing and increasing it.